Immune-Boosted Chemo Cuts Death Risk by a Third in Advanced Esophageal Cancer, Landmark Analysis Finds
A revised meta-analysis of six phase III trials shows first-line PD-1 inhibitor plus chemotherapy reduces the risk of death by ...
A revised meta-analysis of six phase III trials shows first-line PD-1 inhibitor plus chemotherapy reduces the risk of death by ...
A network meta-analysis of 58 phase III trials covering 36,664 patients ranks the safety of 20 immune checkpoint inhibitors combined ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine